SCHEMBL18376604

SCHEMBL18376604

COc1ccc(-c2cccc3cnc(Nc4cccc(N5CCN(CCC#N)CC5)c4)nc23)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ FGFR2 P21802 2/20 0.48
▸ CYP1A2 P05177 6/20 0.48
▸ CYP3A4 P08684 5/20 0.48
▸ MEN1 O00255 5/20 0.48
▸ USP2 O75604 5/20 0.48
▸ CASP1 P29466 5/20 0.48
▸ CASP7 P55210 5/20 0.48
▸ KMT2A Q03164 5/20 0.48
▸ HBB P68871 4/20 0.48
▸ TSHR P16473 2/20 0.48
▸ TTK P33981 3/20 0.46
▸ FGFR1 P11362 1/20 0.45
▸ KDR P35968 1/20 0.45
▸ JAK2 O60674 4/20 0.45
▸ BRD4 O60885 2/20 0.45
▸ MAPK1 P28482 2/20 0.44
▸ CLK4 Q9HAZ1 1/20 0.44
▸ BRCA1 P38398 2/20 0.44
▸ PTK2 Q05397 4/20 0.43
▸ JAK3 P52333 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29370862 1.00 FGFR2 (0.48) FGFR2CYP1A2CYP3A4MEN1USP2
SCHEMBL29368470 0.92 TTK (0.47) FGFR2CYP1A2CYP3A4MEN1USP2
SCHEMBL18376791 0.92 TTK (0.47) FGFR2CYP1A2CYP3A4MEN1USP2
SCHEMBL29370825 0.90 FGFR2 (0.51) FGFR2TTKFGFR1KDRJAK2
SCHEMBL18376788 0.90 FGFR2 (0.58) FGFR2TTKFGFR1KDRJAK2
SCHEMBL18376603 0.90 FGFR2 (0.51) FGFR2TTKFGFR1KDRJAK2
SCHEMBL18377065 0.88 PTK2 (0.55) FGFR2TTKFGFR1KDRJAK2
SCHEMBL29368482 0.88 PTK2 (0.55) FGFR2TTKFGFR1KDRJAK2
SCHEMBL29371334 0.87 JAK2 (0.56) CYP3A4TTKFGFR1KDRJAK2
SCHEMBL18376246 0.87 JAK2 (0.56) CYP3A4TTKFGFR1KDRJAK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113999180-A Quinazoline compound, intermediate thereof, preparation method, pharmaceutical composition and application 上海医药集团股份有限公司 2022-02-01 — — CN claimed
CN-113999180-B Quinazoline compound, intermediate, preparation method, pharmaceutical composition and application 上海医药集团股份有限公司 2024-03-26 — — CN disclosed
CN-113999180-A Quinazoline compound, intermediate thereof, preparation method, pharmaceutical composition and application 上海医药集团股份有限公司 2022-02-01 — — CN disclosed
CN-106316965-B Quinazoline compound, intermediate thereof, preparation method, pharmaceutical composition and application 上海医药集团股份有限公司 2021-08-27 — — CN disclosed
WO-2017005137-A1 QUINAZOLINE COMPOUND, INTERMEDIATE, PREPARATION METHOD, PHARMACEUTICAL COMPOSITION AND USES THEREOF 吉林大学 2017-01-12 — — WO disclosed
Send feedback